Spatially Fractionated Radiotherapy for Tumor Treatment

Clinical trial NCT07774819 · RECRUITING

Trial details

NCT number: NCT07774819
Sponsor: Xu Zhi-yuan
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Radiotherapy-Induced Immune Priming

Start date: 2024-12-19
Primary completion: 2028-12-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.